ESTUTC-5 New YorkLog in Sign up

CTY
City Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 11, 2026 12:51:24 PM EST

20.19USD+3.274%(+0.64)142,826

17.35Bid23.41Ask6.06Spread

Loading…

Loading…

1.01B

Sector

Information

Industry

Telecommunications Resellers

HQ

Monroe, Louisiana, USA

Previous Close

$19.62

Beta

-0.94

52-Week High

$23.88 2026-10-16

52-Week Low

$15.81 2026-11-05

SMA 50

$23.43

SMA 200

$23.37

Avg. Vol 10D

263,751

Avg. Vol 30D

231,836

Avg. Vol 90D

113,356

Relative Vol

0.62

50.33M

50.33M

100.00%

822,840

Short Interest %

1.63%

2.27

On/Off Exchange

48%/52%

66.34%

Short Vol % (off-exch)

52.38%

7.3800%

200,000

1,500

5,672

15,295

Nov 10, 2026

10:08 AM ESTCTY Initiates Coverage by Jefferies -- Price Target Announced at $32 ·

GuruFocus

08:33 AM ESTCTY Initiated Coverage by Oppenheimer -- Price Target Set at $46.00 ·

GuruFocus

07:36 AM ESTCTY Initiated Coverage by Goldman Sachs -- Early-Stage Biotech Rating ·

GuruFocus

07:00 AM ESTCity Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease ·

GlobeNewswire Inc.

06:11 AM ESTGoldman Sachs initiates City Therapeutics stock at Early-Stage Biotech ·

Investing.com

CTY Performance

Period	Price	Date	Change	Beta
1W	16.41	2026-11-04	+22.38%	-0.099
1M	22.40	2026-10-16	-10.34%	-0.945

CTY Stock Summary

City Therapeutics, Inc. Common Stock (NASDAQ:CTY) stock price today is $20.08, and today's volume is 142,823. CTY is up 2.359% today. The 30 day average volume is 231,836. CTY market cap is $1.01B with 50.33M shares outstanding.